Skip to main content
. 2018 Sep 16;2018:5072987. doi: 10.1155/2018/5072987

Figure 1.

Figure 1

Patient flow for the training cohort (a) and validation cohort (b). Chemotherapy included mFOLFOX6 and FOLFIRI.